|   GCN2-IN-1 structure | Common Name | GCN2-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 1448693-69-3 | Molecular Weight | 402.413 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 760.0±70.0 °C at 760 mmHg | |
| Molecular Formula | C19H18N10O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 413.4±35.7 °C | |
| Use of GCN2-IN-1GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay. | 
| Name | GCN2-IN-1 | 
|---|---|
| Synonym | More Synonyms | 
| Description | GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay. | 
|---|---|
| Related Catalog | |
| Target | IC50: <0.3 μM (GCN2)[1] | 
| In Vitro | GCN2-IN-1 (Compound A-92) is a GCN2 inhibitor, which may be useful as a chemotherapeutic drug for the treatment of cancer[1]. | 
| References | 
| Density | 1.7±0.1 g/cm3 | 
|---|---|
| Boiling Point | 760.0±70.0 °C at 760 mmHg | 
| Molecular Formula | C19H18N10O | 
| Molecular Weight | 402.413 | 
| Flash Point | 413.4±35.7 °C | 
| Exact Mass | 402.166504 | 
| LogP | 0.87 | 
| Vapour Pressure | 0.0±2.6 mmHg at 25°C | 
| Index of Refraction | 1.902 | 
| Storage condition | -20℃ | 
| MFCD30345302 | 
| 3-(1H-Indazol-6-yl)-N-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine | 
| 3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine, 3-(1H-indazol-6-yl)-N-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]- |